Emerging Life-Sciences Markets: New Partnerships, New Competitors

Article

Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.

BioPharm International

eBooks Volume 28, Issue 14  

Distant destinations have never looked better for multinational and middle market life-sciences companies. While multinationals fill their innovation pipelines in North America, branded and generic-drug producers alike are finding fertile ground for growth in new markets in Asia and Latin America.   Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.    

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Related Content
Car T-cell therapy is illustrated in an engaging way, showcasing the innovative fusion of biotechnology and medicine for advanced cancer treatment solutions | Image Credit: © Zeeshan - stock.adobe.com.

Biopharm Industry Impacts of FDA Eliminating REMS for CAR-T Therapies

Christopher Cole
June 30th 2025
Article

Regulatory shift reflects maturation of CAR-T field and impacts biopharm manufacturing, development, and discovery.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Positive Early Data Seen in COVID-19 Monoclonal Antibody Treatment

Susan Haigney
June 26th 2025
Article

The next-generation monoclonal antibody could potentially be used to prevent and treat active COVID-19 infections, according to its developer, providing a non-vaccine option.

3d rendered genetic illustration of human dna under microscope created with generative ai technology | Image Credit: © Picture Office - stock.adobe.com.

SynaptixBio Responds to UK’s £650M Genomics Initiative with Call for Implementation Clarity

Christopher Cole
June 26th 2025
Article

The biotech company urges government action to support newborn genome screening, emphasizing the need for rare disease care, testing, and family resources.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EDQM Announces Digital Version of the European Pharmacopoeia

Susan Haigney
June 26th 2025
Article

EDQM is providing the 12th edition of the European Pharmacopoeia as an all-digital, redesigned, user-friendly issue.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

EMA Conditionally Authorizes Stem Cell Therapy for Blood Cancers

Susan Haigney
June 23rd 2025
Article

The agency has recommended conditional marketing authorization for Zemcelpro (dorocubicel/unexpanded umbilical cord cells) to treat adults with hematological malignancies (blood cell cancers).

UAE flag waving in the sky, national symbol of UAE | Image Credit: © Freelancer - stock.adobe.com

Abu Dhabi Health Department's US Mission Yields Multiple Strategic Agreements

Patrick Lavery
June 20th 2025
Article

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

© 2025 MJH Life Sciences

All rights reserved.